After working with patients that have both thyroid disease
and degenerative spinal disease and/or sciatica, I suspected that these
conditions were related somehow. It became clear that there are many
connections.
Generalized joint laxity is thought to be a risk factor for
the development of degenerative spondylolisthesis1,2, and hypothyroidism is a cause
of joint laxity3,4. In children, hypothyroidism
can cause abnormal development of the spine, leading to wedge-shaped lumbar
vertebrae which are predisposed to spondylolisthesis5. Hypothyroidism may also be
related to ossification of the posterior longitudinal ligament, which is a
cause of spinal stenosis6. In addition, degenerative
disc disease is common in patients with autoimmune thyroid disease7.
It was recently discovered that the hormone triiodothyronine
(T3) is important in the synthesis and cross-linking of collagen type I8. Analysis of disc material of
patients with spondylolisthesis shows a deficiency of collagen type I9. Is it possible that lack of
normal thyroid hormone leads to a deficiency in collagen, creating joint laxity
and degenerative spinal disease?
Another interesting angle to look at is the use of iodine
baths to treat lumbosacral radiculopathy10,11. It is astonishing to find
that instances of iodine in treatment of sciatica dates back to the mid 1800’s,
even though the full connections between iodine and the thyroid, thyroid
hormones and collagen, and collagen and ligament laxity, and ligament laxity
and degenerative spinal disease were not known until recently.
Historical use of iodine in treatment of back pain and sciatica. |
Iodine, aside from supporting normal thyroid hormone, and in
turn, collagen production, has separate anti-inflammatory and antioxidant
effects that could explain its historical usage for back pain. Iodine can lower
C-reactive protein, and Interleukin-612, which are inflammatory
cytokines involved in the pathogenesis of sciatica and radiculopathy13,14. Iodine also acts as an
antioxidant and protects against reactive oxygen species15, which contribute to
neuropathic pain16, and increases plasma
glutathione peroxidase15.
1. Matsunaga, S., Sakou, T., Morizono, Y.,
Masada, A. & Demirtas, A. M. Natural history of degenerative
spondylolisthesis: pathogenesis and natural course of the slippage. Spine
15, 1204–1210 (1990).
2. Bird, H., Eastmond, C., Hudson, A. & Wright, V. Is generalized joint laxity a factor in spondylolisthesis? Scand. J. Rheumatol. 9, 203–205 (1980).
3. Dorwart, B. B. & Schumacher, H. R. Joint effusions, chondrocalcinosis and other rheumatic manifestations in hypothyroidism: a clinicopathologic study. Am. J. Med. 59, 780–790 (1975).
4. Golding, D. N. The musculo-skeletal features of hypothyroidism. Postgrad. Med. J. 47, 611 (1971).
5. Hefti, F. et al. Pediatric Orthopedics in Practice. (Springer, 2007).
6. Kalb, S., Martirosyan, N. L., Perez-Orribo, L., Kalani, M. Y. S. & Theodore, N. Analysis of demographics, risk factors, clinical presentation, and surgical treatment modalities for the ossified posterior longitudinal ligament. Neurosurg. Focus 30, E11 (2011).
7. Tagoe, C. E., Zezon, A., Khattri, S. & Castellanos, P. Rheumatic manifestations of euthyroid, anti-thyroid antibody-positive patients. Rheumatol. Int. 33, 1745–1752 (2013).
8. Varga, F. et al. T3 affects expression of collagen I and collagen cross-linking in bone cell cultures. Biochem. Biophys. Res. Commun. 402, 180–185 (2010).
9. Roberts, S., Beard, H. & O’Brien, J. Biochemical changes of intervertebral discs in patients with spondylolisthesis or with tears of the posterior annulus fibrosus. Ann. Rheum. Dis. 41, 78 (1982).
10. Sichinava, N. V., Stiazhkina, E. M., Gurkina, M. V., Iashina, I. V. & Nuvakhova, M. B. [Physical rehabilitation of the patients presenting with dorsopathies following decompression surgery in the lumbosacral spinal area]. Vopr. Kurortol. Fizioter. Lech. Fiz. Kult. 18–22 (2013).
11. Lysenko, V. V. [Treatment of patients with lumbosacral radiculitis by Krasnodar’ iodine-bromine baths]. Vopr. Kurortol. Fizioter. Lech. Fiz. Kult. 36, 460 (1971).
12. Soriguer, F. et al. Iodine intakes of 100–300 μg/d do not modify thyroid function and have modest anti-inflammatory effects. Br. J. Nutr. 105, 1783–1790 (2011).
13. Kang, J. D. et al. Herniated lumbar intervertebral discs spontaneously produce matrix metalloproteinases, nitric oxide, interleukin-6, and prostaglandin E2. Spine 21, 271–277 (1996).
14. Sturmer, T. Pain and high sensitivity C reactive protein in patients with chronic low back pain and acute sciatic pain. Ann. Rheum. Dis. 64, 921–925 (2005).
15. Winkler, R., Griebenow, S. & Wonisch, W. Effect of iodide on total antioxidant status of human serum. Cell Biochem. Funct. 18, 143–146 (2000).
16. Yowtak, J. et al. Reactive oxygen species contribute to neuropathic pain by reducing spinal GABA release. PAIN 152, 844–852 (2011).
2. Bird, H., Eastmond, C., Hudson, A. & Wright, V. Is generalized joint laxity a factor in spondylolisthesis? Scand. J. Rheumatol. 9, 203–205 (1980).
3. Dorwart, B. B. & Schumacher, H. R. Joint effusions, chondrocalcinosis and other rheumatic manifestations in hypothyroidism: a clinicopathologic study. Am. J. Med. 59, 780–790 (1975).
4. Golding, D. N. The musculo-skeletal features of hypothyroidism. Postgrad. Med. J. 47, 611 (1971).
5. Hefti, F. et al. Pediatric Orthopedics in Practice. (Springer, 2007).
6. Kalb, S., Martirosyan, N. L., Perez-Orribo, L., Kalani, M. Y. S. & Theodore, N. Analysis of demographics, risk factors, clinical presentation, and surgical treatment modalities for the ossified posterior longitudinal ligament. Neurosurg. Focus 30, E11 (2011).
7. Tagoe, C. E., Zezon, A., Khattri, S. & Castellanos, P. Rheumatic manifestations of euthyroid, anti-thyroid antibody-positive patients. Rheumatol. Int. 33, 1745–1752 (2013).
8. Varga, F. et al. T3 affects expression of collagen I and collagen cross-linking in bone cell cultures. Biochem. Biophys. Res. Commun. 402, 180–185 (2010).
9. Roberts, S., Beard, H. & O’Brien, J. Biochemical changes of intervertebral discs in patients with spondylolisthesis or with tears of the posterior annulus fibrosus. Ann. Rheum. Dis. 41, 78 (1982).
10. Sichinava, N. V., Stiazhkina, E. M., Gurkina, M. V., Iashina, I. V. & Nuvakhova, M. B. [Physical rehabilitation of the patients presenting with dorsopathies following decompression surgery in the lumbosacral spinal area]. Vopr. Kurortol. Fizioter. Lech. Fiz. Kult. 18–22 (2013).
11. Lysenko, V. V. [Treatment of patients with lumbosacral radiculitis by Krasnodar’ iodine-bromine baths]. Vopr. Kurortol. Fizioter. Lech. Fiz. Kult. 36, 460 (1971).
12. Soriguer, F. et al. Iodine intakes of 100–300 μg/d do not modify thyroid function and have modest anti-inflammatory effects. Br. J. Nutr. 105, 1783–1790 (2011).
13. Kang, J. D. et al. Herniated lumbar intervertebral discs spontaneously produce matrix metalloproteinases, nitric oxide, interleukin-6, and prostaglandin E2. Spine 21, 271–277 (1996).
14. Sturmer, T. Pain and high sensitivity C reactive protein in patients with chronic low back pain and acute sciatic pain. Ann. Rheum. Dis. 64, 921–925 (2005).
15. Winkler, R., Griebenow, S. & Wonisch, W. Effect of iodide on total antioxidant status of human serum. Cell Biochem. Funct. 18, 143–146 (2000).
16. Yowtak, J. et al. Reactive oxygen species contribute to neuropathic pain by reducing spinal GABA release. PAIN 152, 844–852 (2011).